Objective: Tenofovir use is associated with lower risk of mother-to-infant transmission of the virus and discontinuation of the treatment is not safe. However, the safety of the drug during pregnancy and breast-feeding is not clear. In this study, we aimed to determine of tenofovir concentration in plasma of mother-infant pairs along with breast milk in chronic hepatitis B patients during lactation period. Patients and Method: A total of eleven mother-infant pairs were enrolled in the study. All the mothers received tenofovir disoproxil fumarate (TDF) 245 mg/day for at least one month because of chronic hepatitis B infection. Maternal blood, breast milk and infant blood samples were obtained concomitantly. Tenofovir concentrations were determined by liquid chromatography tandem mass spectrometry method. Results: The median concentrations of tenofovir in maternal plasma and breast milk samples were 88.44 (IQR: 62.47-116.17) ng/mL, 6.69 (IQR: 4.88-7.03) ng/mL, respectively. Tenofovir concentrations were undetectable (<4 ng/mL) in all of the infant plasma samples. The ratio of tenofovir concentration in breast milk/maternal plasma was 0.07. Conclusion: Tenofovir disoproxil fumarate passes through the breast milk in a small amount. Infants had no detectable tenofovir level in their plasma. Our study suggests that tenofovir disoproxil fumarate treatment is safe during breastfeeding period in chronic hepatitis B patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.